• Tigermed to snag top-end price for $1.4bn Hong Kong IPO

    Hangzhou Tigermed Consulting is set to pocket HK$10.7bn ($1.38bn) from its Hong Kong secondary listing, with solid support from Chinese and global investors driving final pricing to the top of guidance.

    • 31 Jul 2020
  • Tigermed hones in on $1.4bn HK secondary listing

    Hangzhou Tigermed Consulting, a biopharmaceutical research and development service provider, has covered books on its secondary public offering in Hong Kong on the first day of taking orders.

    • 27 Jul 2020

All International Bonds

Rank Lead Manager Amount $bn No of issues Share %
  • Last updated
  • Today
1 JPMorgan 537.24 2075 9.13%
2 Citi 451.37 1711 7.67%
3 BofA Securities 447.50 1742 7.61%
4 Barclays 319.49 1313 5.43%
5 Goldman Sachs 312.54 1125 5.31%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $bn No of issues Share %
  • Last updated
  • Today
1 BNP Paribas 60.87 123 14.06%
2 Credit Agricole CIB 28.59 93 6.60%
3 Santander 25.41 90 5.87%
4 JPMorgan 23.88 61 5.52%
5 UniCredit 21.51 103 4.97%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $bn No of issues Share %
  • Last updated
  • Today
1 JPMorgan 15.76 106 9.17%
2 Morgan Stanley 15.71 67 9.14%
3 Goldman Sachs 14.87 82 8.65%
4 Citi 12.56 72 7.30%
5 BofA Securities 11.86 62 6.90%